On Their Way

2022 NON PRO TOP 10

Fort Worth, Texas – February 11-20, 2022 Horse/Rider/Pedigree/Owner/Score/Money

1. On The Reydio; Emily Kent; 17G (Reydioactive x Bewitching Ichi x Cat Ichi); Emily Ann Kent; 665 (H:214/ R:220.5/C:230.5); $7,000 2. Dual Smarty; Julia Winders; 17S (Dual Smart Rey x Cats Gabriella Acre x Cats Merada); Julia R. Winders; 658 (H:215/R:218/C:225); $5,194.80 3. Foundloveathooters; Debbie Crafton; 17G (Smooth As A Cat x Rey Lena Rey x Dual Rey); Debbie Crafton; 653 (H:211/R:219.5/C:222.5); $4,329 4. Lil Purple Rein; Trail Townsend; 18G (Once In A Blu Boon x Lil Red Firecat x High Brow Cat); Tripp or Hope Townsend; 652.5 (H:213.5/R:219.5/C:219.5); $3,463.20 5.SCR King Of The Road; Cutter McLaughlin; 17S (Sannman x SCR Crackin Light x Boonlight Dancer); Jay and Wendy McLaughlin; 650 (H:214/R:212.5/C:223.5); $2,770.56 6. Grace Of The Gun; Addison Fjelstad; 18G (Dualin Stargun x Blondies Peppy Grace x Dual Peppy); Addison Fjelstad; 646 (H:213/R: 215/C: 218); $2,251.08 7. Rok N Roll; Pam Myers; 18G (Sannman x Peek Of Faith x Peeka Pep); Pam Myers; 645 (H:215/R:217.5/C:212.5); $1,904.76 8. Rebellious Soul; Tricia Gilson; 18G (Metallic Rebel x Farra Rey x Dual Rey); Tricia Gilson; 643 (H:218/ R:211.5/C:213.5); $1,731.60. 9. Reyzin A Princess; Landon Luce; 18M (Reyzin The Cash x Pink Catty x Catty Hawk); Andrea Luce; 642.5 (H:216/ R:208.5/C:218); $1,298.70 9. Tuff Reyzin; Kenneth Schueller; 18G (Woody Be Tuff x Reyzin x High Brow CD); Kenneth J. Schueller; 642.5 (H:217/R:215.5/C:210); $1,298.70

ON THEIR WAY

On The Reydio may be Emily Kent’s first Derby horse, but he helped her make a big splash by winning the Tres Osos Cow Horse Derby Non Pro Championship.

By Kristin Pitzer Photos by Primo Morales

The Tres Osos Cow Horse Non Pro Derby, held during the 2022 Kalpowar Quarter Horses Celebration of Champions, has historically provided a venue for riders to kick off the show season with their young horses. In the Non Pro division alone, 56 competitors rode for a shot at the championship, which awarded numerous prizes and a hefty paycheck.

One of those exhibitors, Emily Kent, came to Fort Worth, Texas, with the goal of riding her 5-year-old gelding, On The Reydio (Reydioactive x Bewitching Ichi x Cat Ichi), to the win. From the beginning, Kent and On The Reydio were a force to be reckoned with, continuing to build up momentum through the end. Their 665 composite (H:214/R:220.5/C:230.5) won the title and a check worth $7,000.

“It feels pretty awesome,” Kent said. “I started and trained him all by myself, and he’s my first futurity and derby horse. To come here for the first derby of the year after his wins in the Intermediate and Novice Non Pro at the [2021] Hackamore Classic is so cool, and I just wanted to win it again.”

On The Reydio, nicknamed “Conway” after country singer Conway Twitty due to his rebellious nature as a 2-year-old, stepped up in a big way at the show. First up was the rein work, which Kent said isn’t always the gelding’s strong suit. In fact, prior to the show, she and Conway struggled with their turnarounds. It took a little confidence building, thanks to her mom, Leslie, before Kent felt like Conway was ready.

After tying for 10th at last year’s Tres Osos Non Pro Derby, Emily Kent and 2017 gelding On The Reydio claimed the Championship with a composite 665, winning $7,000.

“I was in the makeup pen at my house, and I was turning him around in a bridle and romals. I said, it feels terrible,” Kent recalled. “My mom texted me and said, ‘Emily, that looked so good.’ I decided, what did I have to lose? If she says it looks OK, I’m just going to do it.”

During his run, Conway turned a plus-1 in one direction and a plus-half in the other. The pair marked a 220.5, the highest they have scored together in the reining.

“It really took my mom saying that for me to think, OK, I’m going to try something,” Kent said. “He was so good there. He was just phenomenal.”

In the herd work, a bobble nearly took them out of the competition. Conway tripped and the momentum pulled the rein out of Kent’s hand. It landed above his ears midturn, but Kent grabbed ahold of it, and the gelding stayed hooked through the turn. The pair marked a 214, which kept them in first place in their total score on two.

Going into the cow work, Kent knew she just had to be good. With a decent score, they would probably win, but “good” wasn’t her plan.

“I wanted to be better,” Kent said with a laugh.

She and Conway boxed their cow for a short period of time on the end, then took it down the fence and made two big turns. Kent said normally she would make a third fence turn, but she knew her horse was ready [to circle the cow]. Conway circled the cow tightly in both directions, and when the horn blew, Kent knew they had scored big.

“It was all I could do to not just throw my arm in the air,” Kent said. “I knew I had won it at that point in time.”

The pair scored a huge 230.5, securing their championship. In addition to their prizes, they also collected the Chrome Cash Incentive, worth $810.

Kent, 18, plans to continue showing Conway, who was bred by EE Ranches Inc., and said she can’t wait to get him in the bridle and compete at the World’s Greatest Youth Horseman, presented by MARS EQUESTRIAN™, next year. She thanked her parents, including her dad, Shawn, for their help. She also thanked her cutting horse trainer, Kody Porterfield, and his crew, and gave a special mention to trainers Chris and Sarah Dawson, who have supported her for many years.

“You know it’s good when Chris stops coaching you and you can just hear him yelling, ‘Go on!’ ” Kent said. “At that point in time, you know you’ve made it.”

NON PRO RESERVE CHAMPION

Non Pro Reserve Champions Julia Winders and Dual Smarty (Dual Smart Rey x Cats Gabriella Acre x Cats Merada) scored a composite 658 (H:215/R:218/C:225) and collected $5,194.80. The 2017 stallion was bred by Todd Nelson.

SPONSOR of the NRCHA 2022

FOR EVERYEQUINEDISCIPLINE

The intramuscular bisphosphonate injection

forcontrol of clinical signs associated with Navicular Syndrome in horses 4 years of age and older

Learn more online www.dechra-us.com www.osphos.com

As with all drugs, side effects may occur. In field studies and post-approval experience the most common side effects reported were signs As with all drugs of discomfort, nervousness, and colic. Other signs reported were: renal insufficiency/failure, anorexia, lethargy, hypercalcemia, behavioral disorders, hyperkalemia, hyperactivity, recumbency, hyperthermia, injection site reactions, muscle tremor, urticaria, hyperglycemia, and fracture. In some cases, death has been reported as an outcome of these adverse events. The safe use of OSPHOS has not been evaluated in horses less than 4 years of age or breeding horses. OSPHOS should not be used in pregnant or lactating mares, or mares intended for breeding. NSAIDs should not be used concurrently with OSPHOS. Concurrent use of NSAIDs with OSPHOS may increase the risk of renal toxicity and acute renal failure. Use of OSPHOS in patients with conditions affecting renal function or mineral or electrolyte homeostasis is not recommended. Refer to the prescribing information for complete details or visit www.dechra-us.com.

Bisphosphonate. For use in horses only. Brief Summary (For Full Prescribing Information, see package insert) CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION: Clodronate disodium is a non-amino, chlorocontaining bisphosphonate. Chemically, clodronate disodium is (dichloromethylene) diphosphonic acid disodium salt and is manufactured from the tetrahydrate form. INDICATION: For the control of clinical signs associated with navicular syndrome in horses. CONTRAINDICATIONS: Horses with hypersensitivity to clodronate disodium should not receive OSPHOS. Do not use in horses with impaired renal function or with a history of renal disease. WARNINGS: Do not use in horses intended for human consumption. HUMANWARNINGS: Not for human use. Keep this and all drugs out of the reach of children. Consult a physician in case of accidental human exposure. PRECAUTIONS: OSPHOS has been associated with renal toxicity. Concurrent administration of other potentially nephrotoxic drugs should be approached with caution and renal function should be monitored. Use of bisphosphonates in patients with conditions or diseases affecting renal function is not recommended. Horses should be well-hydrated prior to and after the administration of OSPHOS due to the potential for adverse renal events. Water intake and urine output should be monitored for 3-5 days post-treatment and any changes from baseline should elicit further evaluation. As a class, bisphosphonates may be associated with gastrointestinal and renal toxicity. Sensitivity to drug associated adverse reactions varies with the individual patient. Renal and gastrointestinal adverse reactions may be associated with plasma concentrations of the drug. Bisphosphonates are excreted by the kidney; therefore, conditions causing renal impairment may increase plasma bisphosphonate concentrations resulting in an increased risk for adverse reactions. Concurrent administration of other potentially nephrotoxic drugs should be approached with caution and renal function should be monitored. Use of bisphosphonates in patients with conditions or diseases affecting renal function is not recommended. Administration of bisphosphonates has been associated with abdominal pain (colic), discomfort, and agitation in horses. Clinical signs usually occur shortly after drug administration and may be associated with alterations in intestinal motility. In horses treated with OSPHOS these clinical signs usually began within 2 hours of treatment. Horses should be monitored for at least 2 hours following administration of OSPHOS. Bisphosphonates affect plasma concentrations of some minerals and electrolytes such as calcium, magnesium and potassium, immediately post-treatment, with effects lasting up to several hours. Caution should be used when administering bisphosphonates to horses with conditions affecting mineral or electrolyte homeostasis (e.g. hyperkalemic periodic paralysis, hypocalcemia, etc.). The safe use of OSPHOS has not been evaluated in horses less than 4 years of age. The effect of bisphosphonates on the skeleton of growing horses has not been studied; however, bisphosphonates inhibit osteoclast activity which impacts bone turnover and may affect bone growth. Bisphosphonates should not be used in pregnant or lactating mares, or mares intended for breeding. The safe use of OSPHOS has not been evaluated in breeding horses or pregnant or lactating mares. Bisphosphonates are incorporated into the bone matrix, from where they are gradually released over periods of months to years. The extent of bisphosphonate incorporation into adult bone, and hence, the amount available for release back into the systemic circulation, is directly related to the total dose and duration of bisphosphonate use. Bisphosphonates have been shown to cause fetal developmental abnormalities in laboratory animals. The uptake of bisphosphonates into fetal bone may be greater than into maternal bone creating a possible risk for skeletal or other abnormalities in the fetus. Many drugs, including bisphosphonates, may be excreted in milk and may be absorbed by nursing animals. Increased bone fragility has been observed in animals treated with bisphosphonates at high doses or for long periods of time. Bisphosphonates inhibit bone resorption and decrease bone turnover which may lead to an inability to repair micro damage within the bone. In humans,atypical femur fractures have been reported in patients on long term bisphosphonate therapy; however, a causal relationship has not been established. ADVERSE REACTIONS: The most common adverse reactions reported in the field study were clinical signs of discomfort or nervousness, colic and/or pawing. Other signs reported were lip licking, yawning, head shaking, injection site swelling, and hives/pruritus. POST-APPROVAL EXPERIENCE (December 2018): The following adverse events are based on post-approval adverse drug experience reporting. Not all adverse events are reported to FDA/ CVM. It is not always possible to reliably estimate the adverse event frequency or establish a causal relationship to product exposure using these data. The following adverse events are listed in decreasing order of reporting frequency: renal failure, polyuria, polydipsia,abdominal pain, anorexia, lethargy, hypercalcemia, behavioral disorder, discomfort, hyperkalemia, hyperactivity, recumbency, hyperthermia, injection site reactions, muscle tremor, urticaria, hyperglycemia, and fracture. In some cases, death has been reported as an outcome of the adverse events listed above. INFORMATION FORHORSE OWNERS:Owners should be advised to: • NOT administer NSAIDs. • Ensure horses have access to adequate water before and after administration of OSPHOS. • Observe their horse for at least 2 hours post-treatment for signs of colic, agitation, and/or abnormal behavior. • If a horse appears uncomfortable, nervous, or experiences cramping post-treatment, hand walk the horse for 15 minutes. If signs do not resolve contact the veterinarian. • Monitor water intake and urine output for 3-5 days post treatment. • Contact their veterinarian if the horse displays abnormal clinical signs such as changes in drinking and urination, appetite, and attitude. Manufactured for: DechraVeterinary Products 7015 College Blvd., Suite 525, Overland Park, KS 66211 866-933-2472 © 2019 Dechra Ltd.OSPHOS is a registered trademarkof Dechra Ltd. All rights reserved. Approved by FDA under NADA # 141-427

INTERMEDIATE NON PRO CHAMPION AND LIMITED NON PRO CHAMPION

Tricia Gilson rode Rebellious Soul (Metallic Rebel x Farra Rey x Dual Rey) to a 643 (H: 218/R:211.5/C:213.5), winning both the Intermediate and Limited Non Pro titles. The 2018 gelding, who was bred by Tiffany Manion, and his owner collected $2,664 for the Intermediate and $1,332 for the Limited Non Pro.

LIMITED NON PRO CO-RESERVE CHAMPION & LEVEL 1 NON PRO CHAMPION

After scoring a composite 638 (H:207/R:211/C:220), Jace Sheridan, on Blinded By The Storm (Blind Sided x Dew It Flo x Mr Peponita Flo), went home with a $932.40 check for the Limited Non Pro Co-Reserve Championship and another $2,146.50 for winning the Level 1 Non Pro. Blinded By The Storm, a 2017 stallion, was bred by Julie Gibbons.

INTERMEDIATE NON PRO RESERVE CHAMPION

Taking Reserve in the Intermediate Non Pro was Carlene Meeks on 5-year-old Play Sally Play (Play Dual Rey x KF Peptos Sally x Peptos Stylish Oak). Meeks and the Jennifer Anderson-bred mare scored a composite 640.5 (H:212/R:215/C:213.5) and banked $2,131.20.

LIMITED NON PRO CO-RESERVE CHAMPION

Lynne Faust, riding Sann Slinger (Sannman x Pinch Of Doc x Doc Freckles Leo), who was bred by Janice Eaton, collected $932.40 for the Limited Non Pro Co-Reserve Championship. Faust and the 2017 gelding scored a composite 638 (H:213.5/R: 212.5/C:212).

LEVEL 1 NON PRO RESERVE CHAMPION

Julie Donovan rode Her Lucky Cat (Hes One Lucky Cat x Her Kinda Sugar x Some Kinda Okie) to Reserve with a 637.5 score (H:210/R:219/C:208.5), collecting $1,717.20. The 2017 gelding was bred by Larry Grimes.

SELECT NON PRO CHAMPION

A composite score of 645 (H: 215/R: 217.5/C: 212.5) gave Pam Myers and Rok N Roll (Sannman x Peek Of Faith x Peeka Pep) the Select Non Pro Championship. Myers and the 2018 gelding, who was bred by Dee Gragg, garnered $160.

NON PRO BOXING CHAMPION & SELECT NON PRO BOXING CHAMPION

With a composite 658 (H:219/R:219/C:220), Cheryl Chown led the Boxing on The Metal Doctor (Metallic Cat x The Doctress Orders x Dual Rey), a 2016 gelding who was bred by Day Creek Ranch LLC. The pair received a check worth $3,619.98. They also collected the Select Non Pro Boxing title, worth an additional $180.

NON PRO BOXING RESERVE CHAMPION

Julie Gibbons and GAR Sweet Tea (Bamacat x PG Selena x Playgun) earned a 656 composite (H:214.5/R:222/C:219.5) for Reserve. Gibbons and the Mark and Eva Gardiner-bred mare banked $2,895.98.

LEVEL 1 NON PRO BOXING CHAMPION

Niteeprowwler (Don’t Stopp Believin x Shesa Smooth Pepto x Smooth As A Cat), a Jenna Stolting rode Ronald Knutson-bred Kit Kat Royal (Kit Kat Sugar x Little Royal Blue x Smart Little Lena) to a composite 632.5 (H:207/R:214.5/C:211), winning the Level 1 Boxing and collecting $958.23.

LEVEL 1 NON PRO BOXING RESERVE CHAMPION

Got The Money Hunny (Reyzin The Cash x Charmed For Sure x Smart Little Lena) and For the Level 1 Non Pro Boxing Reserve Championship, Dustin Mitchell and homebred stallion Reynmann (Sannman x Love The Reys x Dual Rey)’s 627.5 (H:217/ R:194/C:216.5) landed a $798.53 check.

NON PRO BOXING CHROME CASH

Calley Rae Satriana and Wing Anda Prayer (Meteles Cat x Wings Ofa Lena x Quejanaisalena) scored a 650.5 composite (H:214/R:216.5/C:220), which won the Chrome Cash Incentive and a $1,025 paycheck. The 2017 mare was bred by Marcus Vinicius T. Guimaraes.